Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

Company Overview - Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules aimed at improving the lives of patients with genetically defined rare diseases [3] - The company's lead clinical program is pociredir, a small molecule designed to increase the expression of HbF for the treatment of sickle cell disease (SCD) [3] - Fulcrum employs proprietary technology to identify drug targets that can modulate gene expression, addressing the root cause of gene mis-expression [3] Upcoming Events - Company management will present at the Leerink Partners Global Healthcare Conference in Miami, FL on March 10, 2025, at 1:00 p.m. ET [1] - The presentation will be accessible via a webcast, which will also be available for replay on the company's website for at least 30 days following the event [2]